Carisma Therapeutics Presents Promising New Preclinical Knowledge on Engineered Macrophages for the Remedy of Liver Fibrosis at AASLD The Liver Assembly ® 2024 By Investing.com
New preclinical outcomes help the anti-fibrotic potential of engineered macrophages in a…
MIRA Prescription drugs inventory rated ‘Purchase’, cites pre-clinical developments – Ascendiant By Investing.com
On Monday, Ascendiant Capital initiated protection on NASDAQ:MIRA, MIRA Prescription drugs Inc.…
